Evoke Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.52 | -$2.52 | -$2.52 |
| Q2 2024 | 1 | -$0.72 | -$0.72 | -$0.72 |
| Q3 2024 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q4 2024 | 1 | -$0.63 | -$0.63 | -$0.63 |
Evoke Pharma, Inc. Earnings Date And Information
Evoke Pharma, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.94 earnings per share for the quarter, missing analysts' consensus estimates of $-0.38 by $0.56. The company had revenue of 2.65 M for the quarter and had revenue of 5.18 M for the year. Evoke Pharma, Inc. has generated $-28 earnings per share over the last year ($-27.97 diluted earnings per share) and currently has a price-to-earnings ratio of -1.02. Evoke Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Evoke Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.38 | -$0.94 | -0.56 | $3.36 M | $2.65 M |
| 08/13/2024 | Q2 2024 | -$0.72 | -$0.93 | -0.21 | $2.98 M | $2.55 M |
| 05/14/2024 | Q1 2024 | -$0.21 | -$2.09 | -1.88 | $1.74 M | |
| 05/14/2024 | Q4 2023 | -$0.21 | -$7.13 | -6.92 | $1.68 M | |
| 11/09/2023 | Q3 2023 | -$0.62 | -$6.08 | -5.46 | $1.26 M | $1.56 M |
| 08/10/2023 | Q2 2023 | -$0.73 | -$6.70 | -5.97 | $1.10 M | $1.13 M |
| 05/15/2023 | Q1 2023 | -$0.58 | -$8.81 | -8.23 | $810,408 | |
| 03/21/2023 | Q4 2022 | $0.53 | -$6.36 | -6.89 | $796,370 | |
| 11/09/2022 | Q3 2022 | -$0.66 | -$7.23 | -6.57 | $572,000 | $832,100 |
| 08/10/2022 | Q2 2022 | -$0.60 | -$8.47 | -7.87 | $580,000 | $461,795 |
| 05/10/2022 | Q1 2022 | -$5.77 | -$9.55 | -3.78 | $418,380 | |
| 03/08/2022 | Q4 2021 | -$0.08 | -$7.37 | -7.29 | $360,571 | |
| 11/10/2021 | Q3 2021 | -$0.07 | -$8.71 | -8.64 | $382,000 | $930,449 |
| 08/12/2021 | Q2 2021 | -$0.08 | -$10.19 | -10.11 | $151,000 | $236,635 |
| 05/12/2021 | Q1 2021 | -$8.65 | -$12.04 | -3.39 | $90,421 | |
| 03/11/2021 | Q4 2020 | -$5.76 | -$12.27 | -6.51 | $23,020 | |
| 11/10/2020 | Q3 2020 | -$14.41 | -$11.73 | 2.68 | $0 | |
| 08/06/2020 | Q2 2020 | -$11.53 | -$40.15 | -28.62 | $0 | |
| 05/12/2020 | Q1 2020 | -$7.21 | -$10.55 | -3.34 | $0 | |
| 03/12/2020 | Q4 2019 | -$8.65 | -$8.40 | 0.25 | $0 |
Evoke Pharma, Inc. Earnings: Frequently Asked Questions
-
When is Evoke Pharma, Inc.'s earnings date?
Evoke Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
-
How can I listen to Evoke Pharma, Inc.'s earnings conference call?
The conference call for Evoke Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Evoke Pharma, Inc.'s conference call transcript?
The conference call transcript for Evoke Pharma, Inc.'s latest earnings report can be read online.
-
How much revenue does Evoke Pharma, Inc. generate each year?
Evoke Pharma, Inc. (:EVOK) has a recorded annual revenue of $5.18 M.
-
How much profit does Evoke Pharma, Inc. generate each year?
Evoke Pharma, Inc. (:EVOK) has a recorded net income of $5.18 M. Evoke Pharma, Inc. has generated $-27.97 earnings per share over the last four quarters.
-
What is Evoke Pharma, Inc.'s price-to-earnings ratio?
Evoke Pharma, Inc. (:EVOK) has a price-to-earnings ratio of -1.02 and price/earnings-to-growth ratio is 0.05.
